Business Context and Reporting Period
NewGenIVF Group Limited filed this Form 6-K on October 5, 2026. The filing reports its issued and outstanding Class A ordinary shares as of the close of business on October 1, 2026.
Key Financial and Share Metrics
The company reported 27,287,002 issued and outstanding Class A ordinary shares. The filing provides no revenue, profit, cash flow, margin, debt, or liquidity figures.
Material Changes
The reported share count followed issuances related to a best efforts offering announced September 30, 2026, conversions of certain outstanding convertible promissory notes, and issuances under the company’s equity line of credit facility. The filing does not specify the number of shares attributable to each source or provide comparable prior-period share data.
Outlook, Risks, and Unusual Items
The filing contains no guidance, outlook, management commentary, or discussion of risks or contingencies. The share issuances and note conversions may be relevant to assessing dilution; their terms and individual share amounts are not stated here.
Investor Verification Points
- Verify the offering, note-conversion, and equity-line terms and the shares issued under each.
- Check subsequent filings for updated share counts and any further dilution.